Scope of the journal

Scope of the Journal involves Molecular Pathobiology, cellular pathobiology, tumor and stem cell biology, metastasis, tumor suppressor, microenvironment and immunology, prevention and epidemiology, integrated systems and technology, therapeutics and targets. View More..

Special Sections

Articles published in the journal will also be included under the special section that falls within the scope of each section. The special sections are as follows:
Cancer stem cells | Innovative Therapies
Carcinogenesis | Organ Specific Cancers
Radiation and Imaging
Epidemiology, Genetics and Genomics

Original ResearchOpen Access

Pancreatic Cancer Incidence, Mortality, and Survival in the SEER 17 Southern and Total United States (2000-2008)

Subi Gandhi
Journal of Cancer Therapeutics & Research 6 : 3

Original ResearchOpen Access

Expression of circulating annexin A2 in hepatic diseases and hepatocellular carcinoma

Ebtesam El-Gezawy, Laila Abdelbaki, Mohamed Zeinel Deen, Sahar Eldeek, Marwa I Abdelgawad
Journal of Cancer Therapeutics & Research 6 : 2

Original ResearchOpen Access

The role of simvastatin in inhibiting migration and proliferation of breast cancer cells through Rho/ROCK signaling pathway

Erwin Danil Yulian, Muchlis Ramli, Rianto Setiabudy, Nurjati Chairani Siregar, Arleni Bustami, Ricky Dosan
Journal of Cancer Therapeutics & Research 5 : 10

Original ResearchOpen Access

Spiritual pain from persistent chemotherapy-induced peripheral neuropathy in colon cancer patients in Japan

Ayumi Kyota, Kiyoko Kanda, Masako Honda, Kenji Nakazawa, Keiko Fujimoto
Journal of Cancer Therapeutics & Research 5 : 9

ReviewOpen Access

The intersection of chance with determinism: definitions and an application

Ken M Anderson, Marvin Rubenstein, Minu Patel
Journal of Cancer Therapeutics & Research 5 : 8

Original ResearchOpen Access

Aberrant NHERF1 expression as a biomarker in lung carcinoma

Deborah Belchis, Nathan Cuka, Neeraj Sharma, Rajni Sharma, Christopher D Gocke
Journal of Cancer Therapeutics & Research 5 : 7

Original ResearchOpen Access

Adjuvant intravesical instillation for primary intermediate and high-risk non-muscle invasive bladder cancer: BCG versus docetaxel

Hoda H Essa, Ahmed M Abd-Alrahim
Journal of Cancer Therapeutics & Research 5 : 6

Original ResearchOpen Access

Selective bladder preserving treatment by radiation therapy concurrent with either paclitaxel and cisplatin or cisplatin alone following a transurethral surgery

Reham Abdel-Wahab, Hoda H Essa, Ahmed Eltaher, Nagham N Omar, Mohamed A Aboziada
Journal of Cancer Therapeutics & Research 5 : 5

Original ResearchOpen Access

Concurrent radiation therapy and docetaxel in adjuvant treatment of locally advanced breast cancer

Samy M Algizawy, Hoda H Essa, AbdelNaser S Zaid
Journal of Cancer Therapeutics & Research 5 : 4

Short reportOpen Access

New York state health care provider participation in clinical trials: a brief report

Pathu Sriphanlop, Danielle M Crookes, Karen Demairo, Darryl Somayaji, Maureen Killackey, Anita McFarlane, Jean LePere, Lina Jandorf
Journal of Cancer Therapeutics & Research 5 : 3

View All articles ..


Prof. G. J. Peters
acting Head for the Laboratory Medical Oncology, VU University Medical Center, Netherlands. The major research interests of Prof. Peters include all aspects of pharmacology of anticancer agents, with emphasis on antifolates, other antimetabolites, platinum analogs, taxanes and more recently anti-signalling agents and third generation targeted-agents.

Senior Editors

Dr. Piero Picci
is presently acting as a Coordinator for IOR Director of the Laboratory of Experimental Oncology and President of the Italian Sarcoma Group and Director Laboratory of Experimental Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy. Dr. Piero is founder and member of the Board of the "Association for Study and Research in Musculo-skeletal Tumors". His major interest are focused on Diagnosis of bone tumors, Musculo-skeletal oncology, Bone tumors and Paediatric orthopaedic oncology.

Prof. Hallgeir Rui
Professor of Cancer Biology, Medical Oncology and Pathology at Thomas Jefferson University, Philadelphia, PA. He serves as the Scientific Director of the Jefferson Breast Care Center and is the Leader of Kimmel Cancer Center's Biology of Breast Cancer Program. Dr. Rui and his team have invented new high-density tissue arraying technology for high-throughput in situ biomarker studies. His major research interest focused on prolactin-JAK-STAT signaling in breast cancer, Loss of active STAT5 is an independent marker of poor prognosis and also an independent predictive marker of resistance to antiestrogen therapy.

Dr. Paolo Fortina
Professor of Cancer Biology, Jefferson Kimmel Cancer Center. He has completed his Ph.D. in Pediatrics, University of Turin School of Medicine, Torino, Italy. He is been acting as Adjunct Associate Professor of Pediatrics, University of Pennsylvania School of Medicine. His major research and Clinical Interest are focused on Genomics, technology and assay development in genomics, SNP genotype and CNV analysis for GWAS, gene discovery, pharmacogenomics .

Dr. Jacques E. Nor
Professor Of Cariology, Restorative Sciences, and Endodontics School of Dentistry, University of Michigan. He is been Honorary Professor, Oral Biology, University of Birmingham, UK. Dr. Nör research interests are focused on the cellular and molecular regulation of tumor angiogenesis. In addition, his research group has worked on the use of stem cells for the engineering of dental pulps.

Prof. Jiaoti Huang
Director, Urologic Pathology, Professor of Pathology and Laboratory Medicine. Dr. Jiaoti has Hospital Affiliation from Ronald Reagan UCLA Medical Center, USA. His research interested is majorly focused on Genitourinary Pathology, Surgical Pathology, Urologic Pathology.

Journal of Cancer Therapeutics & Research Subject Areas

Cancer Biology, Cancer Therapy, Cancer Prevention, Cancer Epidemiology, Oncology, Cancer Genetics, Cancer Genomics, Translational Therapeutics, Lung Cancer, Breast Cancer, Colorectal Cancer, Hepatocellular Carcinoma , Genitourinary Cancer, Gynecologic Cancer, Central Nervous System Tumors, Head and Neck Cancer, Lymphoma, Skin Cancers.